Detalhe da pesquisa
1.
Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.
Cancer Cell
; 12(2): 115-30, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17692804
2.
A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression.
Blood
; 117(8): 2396-404, 2011 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21163924
3.
The role of upregulated miRNAs and the identification of novel mRNA targets in prostatospheres.
Genomics
; 99(2): 108-17, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22206861
4.
Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models.
J Clin Invest
; 133(22)2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725435
5.
Long-term recovery of irradiated prostate cancer increases cancer stem cells.
Prostate
; 72(16): 1746-56, 2012 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22513891
6.
Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma.
Cancer Cell
; 5(2): 191-9, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-14998494
7.
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.
Cancer Cell
; 3(2): 185-97, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12620412
8.
Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer.
Mol Cancer
; 10: 40, 2011 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-21501485
9.
BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer.
Int J Cancer
; 128(8): 1946-54, 2011 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20568112
10.
Identification of vitronectin as an extrinsic inducer of cancer stem cell differentiation and tumor formation.
Stem Cells
; 28(3): 390-8, 2010 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-19998373
11.
Genomic profiling of tumor initiating prostatospheres.
BMC Genomics
; 11: 324, 2010 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20500816
12.
Clinical significance of Polycomb gene expression in brain tumors.
Mol Cancer
; 9: 265, 2010 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-20920292
13.
Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells.
Mol Cancer
; 9: 267, 2010 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-20929579
14.
Integrin ß4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis.
Cancer Res
; 80(4): 771-783, 2020 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31843981
15.
Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive Cells.
Mol Cancer Ther
; 19(8): 1649-1659, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32404408
16.
Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach.
Prostate
; 69(8): 827-37, 2009 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19204913
17.
Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer.
Clin Cancer Res
; 14(19): 6073-80, 2008 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18829485
18.
Androgen receptor expression in prostate cancer stem cells: is there a conundrum?
Cancer Chemother Pharmacol
; 62(5): 921-3, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18075739
19.
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression.
J Clin Invest
; 128(2): 805-815, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29337305
20.
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.
N Engl J Med
; 346(25): 1937-47, 2002 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-12075054